Case Study: a France-based biopharmaceutical company achieves high-impact manuscript publication with FREYR

a France-based biopharmaceutical company achieves high-impact publication with FREYR

A France-based biopharmaceutical company specializing in hematology and anti-thrombotic therapies faced significant challenges in preparing a manuscript for publication. They encountered difficulties in framing a robust study design for a complex phase IIb trial and struggled with manuscript preparation due to multiple add-on therapy indications. They approached FREYR for support in manuscript preparation to source validated clinical literature for a high-impact journal.

FREYR developed a scientifically validated clinical manuscript, ensuring compliance with all necessary regulatory and publication guidelines. They supported the selection of a high-impact journal and effectively addressed reviewer comments. FREYR's solution provided end-to-end publication support, resulting in the successful preparation and publication of a manuscript that met stringent standards for a global readership, fulfilling the client's needs.